Feasibility Phase 2 study of Dose-dense AC or EC followed by PTX for operable breast cancer
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000022097
- Lead Sponsor
- PO Setouchi Breast Project
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. distant metastasis 2. pregnancy or breast feeding 3. history of drug allergy 4. active infection 5. uncontrollable psychosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method